II Annual Immunooncology Congress

Preliminary program

 

Workshops: Thursday December 1st

Congress: Friday December 2nd and Saturday December 3rdnd.

 

Thursday, December 1st, 2016 

WORKSHOP part 1

Chairperson: Gardenia Vargas Parra, MD, PhD.

11:00 a.m.-12:00 p.m. On-site Registration

12:00 p.m.-12:30 p.m. Immuno-Oncology 101 for clinicians

Juan Pablo Márquez Manríquez, MD. Sonora Cancer Research Center, Seattle, WA, USA.

12:30 p.m.-12:45 p.m. Questions & Answers

12:45 p.m.-1:15 p.m. Checkpoint inhibitors in lung cancer and other neoplasias

Omar Macedo Pérez, MD. Mexican National Cancer Institute, Mexico City.

1:15 p.m.-1:45 p.m. Questions & Answers

Keynote Speaker Presentation 

Chairperson: Joel Hernandez Rivera, MD, Ms.

1:45 p.m.-2:45 p.m. Inflammatory breast cancer

Jaime de la Garza Salazar, MD. Mexican National Cancer Institute, Mexico City.

2:45 p.m.-3:45 p.m. LUNCH BREAK 2

WORKSHOP part 2

Chairperson: Alberto Durazo Acuna, MD.

4:00 p.m.-4:30 p.m. Immunogenic chemotherapy in solid tumors

Pedro Alejandro Lucero Diaz, MD. Sonora Cancer Research Center, Ciudad Obregon, Sonora

4:30 p.m.-4:45 p.m. Questions & Answers

4:45 p.m.-5:15 p.m. Adjuvants in cancer Immunotherapy

Esteban Celis, MD, PhD. Georgia Cancer Center, Augusta, GA, USA

5:15 p.m.-5:30 p.m. Questions & Answers

5:30 p.m.-6:00 p.m. Clinical importance of immune infiltration in solid tumors

Jose Antonio Matute Briceño, MD. Sonora Cancer Research Center, Ciudad Obregon, Sonora

6:00 p.m.-6:15 p.m. Questions & Answers

8:00 p.m.-10:00 p.m. Dinner

Sponsored by: Oncologia Molecular Avanzada 

Friday, December 2nd, 2016 

Opening remarks from the lead collaborators of the Sonoran Community

Chairperson: Manuel López Loaiza, BS, MS.

8:00 a.m.-9:20 a.m.

Maria Trevino Munoz, President of the Board of Directors of the Sonora Cancer Research Center

Karmen Aida Diaz Brown, BS. Sonora State Congresswoman

Edgar Fabian Manriquez Barreras. Ciudad Obregon CANACO President

Salvador Icedo Zamora, MD. Ciudad Obregon General Hospital Director 3

Juan Carlos Galvez Ruiz, PhD. UNISON Health Science Department, Campus Cajeme

Perspective from a cancer patient relative

Jose Enrique Rodarte Salazar, BS. Philanthropist

Plenary Session 1: Introduction to Immuno-Oncology

Chairperson: Dolores Gallardo Rincon, MD.

9:20 a.m.-10:00 a.m. Immunology for oncologists

Juan Pablo Marquez Manriquez, MD. Sonora Cancer Research Center, Seattle, WA, USA

10:00 a.m.-10:45 a.m. The link between genetics and immunogenicity

Gardenia Vargas Parra, MD, PhD. Sonora Cancer Research Center, Ciudad Obregon, Sonora

10:45 a.m.-11:30 a.m. CAR-T cells strategies for cancer immunotherapy

Travis Young, PhD. California Institute for Biomedical Research, La Jolla, CA, USA

11:30 a.m.-12:15 p.m. ChemoFit test: Validation of a chemo sensitivity assay for solid tumors

Arvind Thakur, PhD. AccuTheranostics, Clinical & Translational Research Center, Buffalo, NY, USA

12:15 p.m.-1:00 p.m. Repurposing drugs with immune properties for hematological malignancies

Alejandro Camacho Hernandez, MD. Sonora Cancer Research Center, Ciudad Obregon, Sonora

1:00 p.m.-1:15 p.m. Session Discussion

1:15 p.m.-2:00 p.m. LUNCH 4

Plenary Session 2: Immunopharmacology in Cancer Immunotherapy

Chairperson: Francisco Javier Ochoa Carrillo, MD.

2:00 p.m.-2:30 p.m. Clinical immunopharmacology of antibiotics with immunooncology properties

Pedro Alejandro Lucero Díaz, MD. Sonora Cancer Research Center, Ciudad Obregon, Sonora

2:30 p.m.-3:00 p.m. Immunotherapeutic targets for neurotumors

Alberto Durazo Acuña, MD. Sonora Cancer Research Center, Seattle, WA, USA

3:00 p.m.-3:30 p.m. Immunotherapeutic targets in pancreatic ductal adenocarcinoma

Erik Ramos, MD. Sonora Cancer Research Center, Seattle, WA, USA

3:30 p.m.-4:30 p.m. Immunosuppressive pathways in hepatocellular carcinoma patients and beneficial immunomodulation following sorafenib therapy

Keynote Speaker: Yasmin Thanavala, MD, PhD. Roswell Park Cancer Institute, Buffalo, NY, USA

4:30 p.m.-5:00 p.m. Secondary effects of the cancer immunotherapy agents

Jorge Martinez Tlahuel, MD, PhD. Mexican National Cancer Institute, Mexico City

5:00 p.m.-5:15 p.m. Session Discussion

5:15 p.m.-5:45 p.m. Development and optimization of T cell immunotherapy and vaccines for ovarian cancer

Arturo Suplee, MD. Sonora Cancer Research Center, Seattle, WA, USA

5:45 p.m.-6:30 p.m. Ovarian cancer and relapse pattern

Maria Dolores Gallardo Rincon, MD. National Cancer Institute, Mexico City

7:30 p.m.-11:30 p.m. Immunooncology 2016 GALA

Sponsored by: CICS Campus Seattle, WA, USA 5

 

Saturday, December 3rd, 2016

Plenary Session 3: Immune infiltrate and cancer

Chairperson: Raquel Gerson, M.D.

8:00 a.m.-8:45 a.m. Lymphocytic infiltration in colorectal cancer

Luis F. Oñate Ocaña, MD. Mexican National Cancer Institute, Mexico City

8:45 a.m.-9:45 a.m. Engineering better T cells and tumors for adoptive immunotherapy

Keynote speaker: Brad Nelson, PhD. University of British Columbia Canada

9:45 a.m.-10:45 a.m. An oasis in the immune desert: Tumor antigen expression and spontaneous immune responses in patients with T cell-poor ovarian tumors

David Kroeger, PhD. University of British Columbia, Canada

10:45 a.m.-11:30 a.m. Immuno-Oncology in pediatric malignancies: collaborations are going to start

Adriana Bello Cedres, MD. Trinidad Medical Center, Caracas, Venezuela

11:30 a.m.-12:30 p.m. Understanding and neutralizing cancer induced immunosuppression to promote anti-tumoral immunity

Keynote speaker: Suzanne Ostrand-Rosenberg, PhD. University of Maryland, Baltimore, USA

12:30 p.m.-12:45 p.m. Session Discussion

12:45 p.m.-1:45 p.m. LUNCH BREAK

Chairperson: Claudia Arce Salinas, M.D. 6

1:45 p.m.-2:30 p.m. Blocking β-adrenergic receptor signaling restores endogenous immune control of murine tumor models and improves responses to anti-PD-1 checkpoint blockade in mice housed at sub-thermoneutral housing temperatures

Mark J. Bucsek, BS. Roswell Park Cancer Institute, Buffalo, NY, USA

2:30 p.m.-3:30 p.m. Adrenergic stress signaling in laboratory mice results in immunosuppression and an increase in the resistance of experimental tumors to radiation and chemotherapy

Keynote Speaker: Elizabeth Repasky, PhD. Roswell Park Cancer Institute, Buffalo, NY, USA

3:30 p.m.-4:30 p.m. Designing therapeutic cancer vaccines by mimicking viral infections

Keynote speaker: Esteban Celis, MD, PhD. Georgia Cancer Center, Augusta, GA, USA

4:30 p.m.-4:45 p.m. Session Discussion

4:45 p.m.-5:00 p.m. Poster awards presentation

Closing remarks and Departure

Chairperson: Arturo Suplee Rivera, MD.

5:00 p.m.-5:35 p.m. Juan Pablo Marquez Manriquez, MD. Sonora Cancer Research Center, Seattle, WA, USA

Faustino Felix Chavez. Cajeme County Mayor.

Claudia Pavlovich Arellano. Governor of the State of Sonora 7